Akari Therapeutics Plc (AKTX)
Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014
Balance Sheet Date2025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312016-Mar-312015-Dec-312015-Sep-302015-Jun-302015-Mar-312014-Dec-31
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q1-FY2016Q4-FY2015Q3-FY2015Q2-FY2015Q1-FY2015Q4-FY2014
Total Assets47,892,000$45,376,000$50,911,000$50,959,000$50,562,000$2,734,000$5,076,000$2,772,000$4,355,000$13,832,000$62,959,202$69,893,562$79,174,139$2,960,000$4,317,000$3,394,666$
Total Current Assets5,462,000$2,946,000$3,301,000$3,349,000$2,952,000$2,734,000$5,076,000$2,772,000$4,341,000$13,815,000$62,693,347$69,658,487$78,939,029$2,920,000$4,273,000$3,335,249$
Cash and Cash Equivalents2,711,000$2,582,000$2,599,000$2,246,000$4,177,000$1,310,000$3,845,000$13,250,000$61,429,511$68,919,995$78,772,888$2,718,000$1,328,662$3,327,468$52,614$11,358,000$
Receivables
Other Current Assets14,000$53,000$83,000$80,000$201,000$92,000$94,000$232,000$197,000$100,000$
Assets Held for Sale in Short Term
Total Noncurrent Assets42,430,000$42,430,000$47,610,000$47,610,000$47,610,000$0$0$0$14,000$17,000$265,855$235,075$235,110$40,000$44,000$59,417$
Goodwill8,430,000$8,430,000$8,430,000$8,430,000$8,430,000$19,283,280$
Other Intangible Assets14,000$17,000$49,019$52,483$58,099$59,417$
Physical Assets74,757$40,513$34,932$40,000$44,000$0$
Other Noncurrent Assets
Assets Held for Sale in Long Term
Total Liabilities19,564,000$22,689,000$25,306,000$29,213,000$28,333,000$9,428,000$8,779,000$6,325,000$4,584,000$12,041,000$16,601,200$21,174,037$37,842,693$1,987,000$1,722,000$1,171,368$
Total Current Liabilities12,351,000$15,568,000$17,138,000$20,907,000$19,910,000$9,428,000$8,779,000$6,325,000$4,584,000$16,549,100$21,124,968$37,796,655$960,000$910,000$1,171,368$
Accounts Payable8,770,000$10,844,000$11,607,000$13,067,000$12,407,000$4,782,000$4,686,000$3,208,000$1,671,000$947,000$625,372$4,320,588$3,753,518$555,528$
Short Term Debt
Short Term Capital Lease Obligations
Other Current Liabilities449,000$85,000$260,000$796,000$731,000$81,000$41,000$187,000$75,000$128,000$
Total Noncurrent Liabilities7,213,000$7,121,000$8,168,000$8,306,000$8,423,000$0$0$0$0$12,041,000$52,100$49,069$46,038$1,027,000$812,000$0$
Long Term Debt
Long Term Capital Lease Obligations
Other Noncurrent Liabilities31,000$69,000$128,000$266,000$383,000$43,000$38,000$33,000$
Total Equity28,328,000$22,687,000$25,605,000$21,746,000$22,229,000$(6,694,000$)(3,703,000$)(3,553,000$)(229,000$)213,000$2,781,000$6,561,000$1,791,000$5,555,000$46,358,002$48,719,525$41,331,446$973,000$2,595,000$2,223,298$10,415,000$
Equity to Minority
Equity to Common Shareholders28,328,000$22,687,000$25,605,000$21,746,000$22,229,000$(6,694,000$)(3,703,000$)(3,553,000$)(229,000$)213,000$2,781,000$6,561,000$1,791,000$5,555,000$46,358,002$48,719,525$41,331,446$973,000$2,595,000$2,223,298$10,415,000$
Additional Paid-In Capital234,318,000$224,366,000$220,846,000$212,706,000$
Retained Earnings(264,550,000$)(259,252,000$)(252,852,000$)(250,957,000$)(247,252,000$)(243,480,000$)(240,585,000$)(233,027,000$)(227,461,000$)(217,453,000$)(59,781,997$)(56,796,613$)(63,268,903$)(34,178,000$)(32,507,000$)(11,479,081$)
Treasury Stock
Capital Lease Obligations